OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial.
about
OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@en
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@nl
type
label
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@en
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@nl
prefLabel
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@en
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@nl
P2093
P1433
P1476
OA07-04 LB. Immunogenicity of ...... i Phase III HIV vaccine trial.
@en
P2093
J Tartaglia
MS de Souza
NL Michael
R Trichavaroj
S Jongrakthaitae
P304
P356
10.1186/1742-4690-6-S3-O52
P433
P577
2009-10-22T00:00:00Z